Transaction in Own Shares

Summary by AI BETAClose X

GSK plc, through its corporate stockbroker, Merrill Lynch International, purchased 221,293 ordinary shares on August 18, 2025, at a volume-weighted average price of 1,437.72 pence per share, with the lowest price being 1,433.00 pence and the highest price being 1,443.00 pence. These shares will be held as treasury shares, as part of the company's existing buyback program initiated on June 4, 2025. Since June 4, 2025, a total of 24,364,286 ordinary shares have been purchased under this program. After this purchase, GSK will hold 242,498,669 ordinary shares in treasury, and 4,072,893,065 ordinary shares will be in issue (excluding treasury shares). The percentage of voting rights attributable to treasury shares is 5.95 percent. All purchases were made on the London Stock Exchange; no shares were purchased on CBOE (CHIX) or CBOE (BATE).

Disclaimer*

Companies

GSK (GSK)
UK 100

Latest directors dealings